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Abstract: Moving from nano- to micro-systems may not just be a 
matter of scale, but it might imply changes in the properties of the 
systems that can open new routes for the development of efficient 
MRI contrast agents. This is the case reported in the present paper, 
where giant liposomes (Giant Unilamellar Vesicles, GUVs) loaded 
with Ln(III) complexes have been studied as MRI CEST contrast 
agents. The comparison between nanosized liposomes (Small 
Unilamellar Vesicles, SUVs) and GUVs sharing the same formulation 
led to differences that could not be accounted only in term of the mere 
increase in size (from 100-150 nm to 1-2 m). Upon osmotic 
shrinkage GUVs yielded a Saturation Transfer effect of three order of 
magnitude higher than SUVs consistent with the increase in vesicles 
volume. Confocal microscopy showed that the shrinkage of GUVs 
resulted in multilamellar particles whereas SUVs are known to yield 
asymmetrical, discoidal shape.  
MRI takes great advantage from the use of contrast agents as 
they may add functional information to the outstanding anatomical 
resolution attainable by this technique.1 Along the years, most 
attention has been devoted to relaxation enhancers that affect the 
relaxation rates of water protons in the region where they 
distribute.2 In recent years, much attention has been devoted to 
chemicals that allow their detection through procedures based on 
frequency encoding.3 
In this context the most interesting class is represented by 
CEST agents that are chemicals that affect the signal intensity of 
the water proton resonance through the transfer of saturated 
magnetization from their exchangeable proton pool.4 A drawback 
of the CEST agents is represented by their relatively low 
sensitivity as their detection in a MR image requires the number 
of exchangeable protons to be in the millimolar range.5  
An important step ahead along the improvement of the attainable 
sensitivity was achieved with the introduction of LipoCEST in 
which the exchangeable pool of protons is represented by the 
large ensemble of water molecules contained in the liposomal 
inner aqueous cavity whose NMR resonance is properly shifted 
by the presence of paramagnetic shift reagents.5a,6 A further 
sensitivity enhancement has been achieved on passing from 
spherical liposomes to osmotically shrunken ones that yield highly 
shifted values for the intraliposomal water resonance.7 Up to now 
these are among the most sensitive CEST agents (hundreds pM 
for the spherical vesicles to tents pM for the shrunken ones). 
According to their membrane formulation, the shrunken 
LipoCEST are able to orient themselves when exposed to a 
magnetic field providing markedly large effects on the chemical 
shift of the intravesicular water molecules.8 Despite the huge 
potential of these systems, the in vivo use has been hampered 
from macrophagic uptake or cell internalization. In fact, 
paramagnetic liposomes can work as LipoCEST agents as long 
as their content remains inside the vesicles whereas it became 
CEST-invisible when the vesicles undergo a degradation.9 
In this work we have tried to overcome some of the 
limitations and to improve the potential shown by the 
paramagnetic SUVs by increasing their size. Giant Unilamellar 
Vesicles (GUVs) are liposomes of micron size; they have been 
known for over half a century and have been used as cell 
mimicking systems but no use as imaging agents has yet been 
reported. 
These systems have dimensions ranging from 0.8 m to 2 m or 
even higher depending on the methodology of preparation or on 
the membrane formulation.  
GUVs and SUVs bearing the same paramagnetic cargo were 
prepared to assess their differences when they act as LipoCEST 
agents.  
 
Giant liposomes were prepared following the so called “natural 
swelling” method reported in literature with some modifications.10 
Chart 1 summarizes liposomes’ components in the membrane 
and in the internal cavity. The different samples are summarized 
in Table 1. 
 
Table 1. Characteristics of the studied liposomes[a] 
[a] Chemical structures are reported in the Supporting Information.  
Because the size of GUVs was expected to range between 1 and 
3 m, the most common techniques used to characterize the 
particles size (e.g. DLS or FACS) could not be used as their 
Name Formulation Content Size 
Lipo-1 
DPPC/Amphiphilic Tm-
complex/Liss Rhod PE/ 
DSPEmPEG2000 
81.95/15/0.05/3 
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81.95/15/0.05/3 
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DSPEmPEG2000 
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reliability fall in a lower or higher range of detection, respectively. 
Therefore, confocal fluorescence microscopy sampling was 
exploited as the technique for assessing the size of the herein 
prepared giant liposomes and fluorescent formulations were 
prepared for this purpose.  
Figure 1 shows a representative fluorescence microscopy image 
of a spherical GUV and the size distribution; the mean size of 
these giant particles resulted to be 1.22 ± 0.15 m. As reported in 
Figure 1B, the phospholipidic membrane can be easily detected 
by the presence of rhodamine-B-bearing phospholipids (red) and 
the inner aqueous cavity can be visualized by the presence of the 
water soluble 5(6)-carboxyfluorescein (green). 
To investigate the potential of giant liposomes as CEST 
agents (GiantCEST) different formulations were prepared. In 
particular, small and giant liposomes suspensions containing 40 
mM TmHPDO3A (Fig.SI1) in the aqueous cavity and 15% of 
amphiphilic Tm-complex (Fig.SI2) in the membrane were 
prepared and characterized. All the samples were resuspended 
in HEPES/NaCl 0.15 M buffer 300 mOsm/L to induce an osmotic 
stress (shrunken liposomes).4a,7 
Z-spectra were acquired at 600 MHz at different presaturation 
powers. Z-spectra of small and giant liposome suspensions 
sharing the same formulation are reported in Figure 2A and B, 
respectively. 
The intensity of the irradiating field B1 that represented the best 
compromise between maximizing the LipoCEST efficacy and 
minimizing SAR (Specific Absorption Rate)11 issues was 5.5 T. 
At this B1 value the small liposomes suspension resulted to have 
a ST% of 22.15% related to a molar concentration of vesicles of 
3.1x10-8 M whereas the giant liposomes suspension resulted in a 
ST% of 47.56% related to a molar concentration of vesicles of 
2.7x10-11 M. This means that at the same concentration of 
vesicles, GiantCEST sensitivity is at least three order of 
magnitude higher with respect to nanosized LipoCEST, as shown 
in Figure 2C where the ST% is reported as a function of vesicles 
concentration. It is worth noting that the sensitivity threshold is 
about 1.5 pM. Fig.SI3 reports a representative CEST-MR image 
showing that ???? M of GUVs can be clearly detectable by MRI 
(ST%>50%) whereas the same concentration of SUVs is not 
visible.   
Figure 2D displays the saturation transfer peaks measured at 
B1=5.5 T. It is possible to observe that even though giant and 
small vesicles share the same membrane composition and inner 
core payload, the corresponding intraliposomal water shift is quite 
Figure 1. A) Size distribution of fluorescent giant liposomes as measured by 
acquiring confocal fluorescent microscopy images. B) representative confocal 
fluorescence microscopy image of a fluorescent spherical giant liposome. 
 
Figure 2. Z-spectra of suspensions containing 3.1x10-8 M of small Lipo-1 (A) and 2.7x10-11 M of giant Lipo-2 (B) vesicles acquired at 600 MHz at different 
presaturation powers. C) ST% in function on the concentration of vesicles (calculated) for a Lipo-1 (black squares) and Lipo-2 (red circles) suspension. D) ST% 
effect in function of the saturation offset for Lipo-1 (black squares) and Lipo-2 (red circles) suspension. 





different, i.e. 5.16 ppm and 14.0 ppm, respectively. As reported in 
literature, osmotically stressed small liposomes have a strongly 
anisotropic cigar-like shape8b,7,4a and this feature allow them to 
orient in the main magnetic field, hence exploiting the BMS 
contribution to the intraliposomal water shifts.8b The BMS 
contribution is larger with respect to the dipolar one12 so for these 
vesicles it is expected to induce a shift larger than 10 ppm.7,12b 
From the obtained results, giant liposomes intraliposomal shift 
didn’t appear to be affected by the BMS contribution to the same 
extent as it was observed for the small ones. 
To get more insight into the understanding of this unexpected 
behaviour, a giant liposome containing 40 mM Dy-HPDO3A in the 
cavity and 15% amphiphilic Dy-complex in membrane was 
prepared and characterized. Changing the lanthanide metal ion 
from Tm(III) to Dy(III) of the amphiphilic complex inserted in the 
membrane, one goes to vary the sign of the magnetic anisotropy 
of the phospholipidic membrane.13 In the case of the small 
shrunken vesicles the analogous Dy/Tm resulted in a dramatic 
change of their orientation towards the external magnetic field.7 
The evidence that a variation in the orientation has occurred is 
provided from a change in the sign of the BMS contribution to the 
shift (from positive to negative). The two formulations of giant 
vesicles with 15% of amphiphilic Ln-complex in the membrane,  
where Ln is Tm or Dy, were compared. Figure 3 reports the Z-
spectra acquired at 600 MHz at different presaturation powers. 
Surprisingly, in case of giant liposomes containing amphiphilic 
Tm- or Dy- complexes in the membrane, the chemical shift is 
positive in both cases, thus suggesting that the change in the 
orientation observed for the analogous SUVs did not take place.14 
This behavior could be explained hypothesizing that the shape of 
giant liposomes might not be the same as that observed for the 
smaller ones. 
To investigate this possibility, confocal fluorescence microscopy 
images were acquired. To be visualized by confocal fluorescence 
microscopy rhodamine-B-carrying giant liposomes entrapping 
5(6)-carboxyfluorescein were prepared. Two different aliquots 
were put against isotonic and hypertonic HEPES/NaCl buffer to 
generate a spherical and a shrunken liposomes suspension, 
respectively. Osmotically stressed nanosized liposomes react 
towards hypertonic medium changing their spherical shape into a 
cigar-like shape, as reported in literature.8b  
In Figure 4A an image of an isotonic giant liposome in which it is 
possible to appreciate the red burden containing the rhodamine-
B and the green internal cavity due to 5(6)-carboxyfluorescein is 
reported; as expected, the vesicle resulted to be spherical. 
Figures 4B and 4C report to examples of osmotically stressed 
GUVs either as two-dimensional or three-dimensional section, 
respectively. It is possible to appreciate the strongly anisotropic 
but amorphous shape of the vesicle with several invaginations 
due to the osmotic stress.  
In order to evaluate the magnetic behavior of giant liposomes 
toward progressive osmotic stress, a giant liposomes suspension 
containing 40 mM TmHPDO3A in the aqueous cavity and 15% of 
amphiphilic Tm-complex in the membrane was prepared and 
suspended in HEPES/NaCl with increasing osmolarity from an 
isotonic to a highly hypertonic environment (40÷400 mOsm/L). In 
Figure 5, it is clearly visible how the peak of intraliposomal water 
shifts away from the bulk water upon increasing the osmolarity of 
the external medium. At the highest osmotic stress, an 
intraliposomal value of about 30 ppm is reached. 
Figure 5. 1H NMR spectra (600 MHz, 298 K) of a suspension of Lipo-2 
suspended in HEPES/NaCl (pH 7.4) with increasing osmolarity: A) 40 mOsm/L 
(isotonic), B) 150 mOsm/L, C) 300 mOsm/L, D) 400 mOsm/L. 
 
Together with the shift, the osmotic stress also resulted in a 
decrease of the intraliposomal water signal, which is associated 
with a line broadening of the peak. The decrease in the signal 
intensity is the consequence of the osmotic shrinkage of the 
Figure 3. Z-spectra of giant Lipo-2 (top) and giant Lipo-3 (bottom) suspensions 
acquired at 600 MHz at different presaturation powers in order to evaluate the 
BMS contribute. 
Figure 4. Confocal fluorescence microscopy images of A) a spherical isotonic 
giant liposome, B) an osmotically stressed globe spiral-like shaped giant 
liposome C) a 3D section of an osmotically stressed GUV. Both giant 
formulations contain 0.05% Liss Rhod PE in membrane and 20 µM 5(6)-
carboxyfluorescein in the internal cavity. 





vesicle that, besides losing entrapped water, increases the 
concentration of the paramagnetic molecules in the aqueous core, 
thus leading to the shortening of the T2 relaxation time, 
responsible for the broadening of the peak.8b 
Finally, the advantages of using GUVs in comparison to SUVs for 
in vivo applications has been preliminary tested by using cellular 
models. In particular, it has been reported that i) internalization of 
GUVs by macrophages is lower than the one reported for SUVs 
(Fig.SI4 and Fig.SI5) and cells viability in presence of GUVs is the 
same reported for SUVs (Fig.SI16). This makes GUVs potential 
good candidate as CEST MRI CAs for in vivo preclinical 
applications. 
 
In conclusion, the herein reported results show that 
paramagnetically loaded GUVs display a CEST sensitivity 
enhancement of three order of magnitude in respect to analogous 
LipoCEST agents based on nanosized SUVs. Interestingly this 
expected change does not occur as simple follow-up of the 
difference in size between SUVs and GUVs because their 
response to the osmotic changes resulted quite different. Actually 
the changes induced on liposomes by osmotic shrinkage is a topic 
extensively investigated over the years as the effects of changes 
in osmotic pressure on liposomes membrane have been used to 
mimic the transformation of biological membranes in response to 
a number of environmental factors. The changes induced on 
liposomes by osmotic shrinkage have been investigated by 
means of many techniques (TEM, SAXS, Fluorescent microscopy, 
etc.). In general, it has been found that, after the initial decrease 
of the area/lipid ratio, a variety of deformations may occur 
including the increase of membrane area, phase shrinkage, up to 
partial solubilization or pore formation and fusion. The osmotic 
shrinkage is first driven by the water outflow through the bilayer. 
The decrease in size implies a decrease of the area/lipid ratio 
which is accommodated with a deformation that for the small 
SUVs results in a passage from spherical to lens/cigar-shaped 
ones. Likely in the case of GUVs the deformation results in close 
contact of opposite bilayers which yield to an extensive 
rearrangement that, in turn, appears to lead to a multilamellar 
system. However, we cannot exclude that the multi-lamellar 
structure is the result of an extensive breaking of the liposome 
membrane in response to the increased osmotic pressure. It was 
reported that under osmotic stress, the vesicles are often broken 
and large holes open without membrane shrinking.15   
As far as concern the development of new MRI CEST agents, the 
finding that such paramagnetically labelled multilamellar-
structures yields systems analogous to the previously reported 
LipoCEST agents may open new routes for the design of 
innovative contrast agents. 
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